Showing results (11-20 of 35) with videos related to
Sort By:
Pageof 4
Plos One|March 9, 2023
Designing an exploratory phase 2b platform trial in NASH with correlated, co-primary binary endpointsElias Laurin Meyer, Peter Mesenbrink, Nicholas A Di Prospero, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 5, 2011
Once-yearly zoledronic acid and days of disability, bed rest, and back pain: randomized, controlled HORIZON Pivotal Fracture TrialJane A Cauley, Dennis Black, Steven Boonen, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 8, 2009
Potential mediators of the mortality reduction with zoledronic acid after hip fractureCathleen S Colón-Emeric, Peter Mesenbrink, Kenneth W Lyles, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 29, 2011
Effects of antiresorptive treatment on nonvertebral fracture outcomesDawn C Mackey, Dennis M Black, Douglas C Bauer, et al.Journal of Hepatology|October 10, 2022
Platform trials to overcome major shortcomings of traditional clinical trials in non-alcoholic steatohepatitis? Pros and consJuan M Pericàs, Frank Tacke, Quentin M Anstee, et al.Osteoarthritis and Cartilage|February 22, 2026
Feasibility and Predictive Value of Proposed Early Endpoints for Randomized Controlled Trials in Knee OsteoarthritisJamie E Collins, Peter Mesenbrink, Robin Dunn, et al.Journal of the American Geriatrics Society|January 15, 2010
Efficacy and safety of a once-yearly intravenous zoledronic acid 5 mg for fracture prevention in elderly postmenopausal women with osteoporosis aged 75 and olderSteven Boonen, Dennis M Black, Cathleen S Colón-Emeric, et al.BMC Medical Research Methodology|January 17, 2025
Why and how should we simulate platform trials? Learnings from EU-PEARLElias Laurin Meyer, Tobias Mielke, Marta Bofill Roig, et al.Virchows Archiv : an International Journal of Pathology|June 15, 2024
A deep-learning-based model for assessment of autoimmune hepatitis from histology: AI(H)Caner Ercan, Kattayoun Kordy, Anna Knuuttila, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 26, 2010
Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: a randomized, multicenter, double-blind, active-controlled studyEric S Orwoll, Paul D Miller, Jonathan D Adachi, et al.Pageof 4